Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 2851 - 2875 of 15147 in total
The New York City Board of Health strain of Vaccinia is a viral strain used as a component of some smallpox vaccinations. ACAM2000, a percutaneously administered smallpox vaccine that was approved by the FDA in 2007, contains live antigens of this strain.
Approved
Approved
Experimental
Acacia dealbata pollen allergenic extract is used in allergenic testing.
Approved
Northern brown shrimp allergenic extract is used in allergenic testing.
Approved
Rainbow trout allergenic extract is used in allergenic testing.
Approved
Pacific ocean perch allergenic extract is used in allergenic testing.
Approved
Myristica fragrans fruit allergenic extract is used in allergenic testing.
Approved
Pisum sativum whole allergenic extract is used in allergenic testing.
Approved
Coffea arabica seed, roasted allergenic extract is used in allergenic testing.
Approved
Lactuca sativa whole allergenic extract is used in allergenic testing.
Approved
Approved
Experimental
Approved
Experimental
Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 22F individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). It is...
Approved
Matched Description: … under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and
Streptococcus pneumoniae type 8 capsular polysaccharide diphtheria CRM197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 8 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides...
Approved
Pucotenlimab is a recombinant humanized anti-PD-1 monoclonal antibody. It received its first global approval in China in July 2022 for the treatment of solid tumours. It is being investigated in other cancers.
Approved
Investigational
Coccidioides immitis spherule is a skin test antigen indicated to detect delayed-type hypersensitivity to Coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis.
Approved
Displaying drugs 2851 - 2875 of 15147 in total